- Corporate Officers - S
- Short Jay M Phd
Insider Trading History of Short Jay M Phd
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Short Jay M Phd since 2007.
This trader's CIK number is 1205375.
At the time of last reporting, Short Jay M Phd was the Chief Executive Officer of Bioatla, Inc.. (stock ticker symbol BCAB).
Also see all insider trading activities at Bioatla, Inc..
Note that in the past
SHORT JAY M PHD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Senomyx Inc (SNMX) by Short Jay M Phd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | SNMX | 0 | $0 | 23,180 | $211,334 | 23,180 | $80,513 |
Yearly summary of insider trading at Bioatla, Inc. (BCAB) by Short Jay M Phd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | BCAB | 90,800 | $207,757 | 0 | $0 | 0 | $0 |
| 2022 | BCAB | 95,740 | $404,957 | 0 | $0 | 0 | $0 |
| 2021 | BCAB | 0 | $0 | 199,499 | $6,061,394 | 7,747 | $139,446 |
Yearly summary of insider trading at Invitrogen Corp (IVGN) by Short Jay M Phd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | IVGN | 0 | $0 | 16,300 | $1,452,543 | 30,346 | $1,324,493 |
| 2007 | IVGN | 0 | $0 | 3,500 | $312,515 | 5,500 | $49,600 |
Insider trading activities at 3 companies by Short Jay M Phd:
1. Senomyx Inc (SNMX)
2. Bioatla, Inc. (BCAB)
3. Invitrogen Corp (IVGN)
Table 1. Insider trading of Senomyx Inc (SNMX) by Short Jay M Phd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-10-01 | SNMX | Sale | 7,500 | 8.16 | 61,200 |
| 2014-10-01 | SNMX | Option Ex | 7,500 | 1.58 | 11,850 |
| 2014-04-01 | SNMX | Option Ex | 11,590 | 3.80 | 44,042 |
| 2014-04-01 | SNMX | Sale | 11,590 | 10.66 | 123,549 |
| 2014-01-14 | SNMX | Option Ex | 4,090 | 6.02 | 24,621 |
| 2014-01-14 | SNMX | Sale | 4,090 | 6.50 | 26,585 |
Table 2. Insider trading of Bioatla, Inc. (BCAB) by Short Jay M Phd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-20 | BCAB | Buy | 50,000 | 2.14 | 106,900 |
| 2023-03-29 | BCAB | Buy | 40,800 | 2.47 | 100,857 |
| 2022-08-12 | BCAB | Buy | 26,350 | 7.84 | 206,610 |
| 2022-06-21 | BCAB | Buy | 29,082 | 2.79 | 81,051 |
| 2022-06-22 | BCAB | Buy | 40,308 | 2.91 | 117,296 |
| 2021-12-02 | BCAB | Sale | 4,811 | 22.11 | 106,351 |
| 2021-11-30 | BCAB | Sale | 18,490 | 24.68 | 456,407 |
| 2021-12-01 | BCAB | Sale | 24,321 | 23.23 | 564,855 |
| 2021-11-29 | BCAB | Sale | 15,435 | 23.89 | 368,742 |
| 2021-11-22 | BCAB | Sale | 15,675 | 26.23 | 411,233 |
| 2021-11-23 | BCAB | Sale | 24,943 | 25.16 | 627,565 |
| 2021-11-24 | BCAB | Sale | 17,022 | 24.94 | 424,545 |
| 2021-08-24 | BCAB | Option Ex | 7,747 | 18.00 | 139,446 |
| 2021-08-24 | BCAB | Sale | 4,533 | 41.60 | 188,572 |
| 2021-06-17 | BCAB | Sale | 19,269 | 39.22 | 755,749 |
| 2021-06-21 | BCAB | Sale | 55,000 | 39.23 | 2,157,375 |
Table 3. Insider trading of Invitrogen Corp (IVGN) by Short Jay M Phd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-05-01 | IVGN | Sale | 2,500 | 94.59 | 236,487 |
| 2008-05-01 | IVGN | Option Ex | 2,500 | 21.04 | 52,600 |
| 2008-02-08 | IVGN | Option Ex | 27,846 | 45.68 | 1,271,893 |
| 2008-02-08 | IVGN | Sale | 13,800 | 88.12 | 1,216,056 |
| 2007-11-01 | IVGN | Option Ex | 3,500 | 12.00 | 42,000 |
| 2007-11-01 | IVGN | Sale | 3,500 | 89.29 | 312,515 |
| 2007-07-20 | IVGN | Option Ex | 2,000 | 3.80 | 7,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Short Jay M Phd
(Chief Executive Officer of Bioatla, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.